Misgav, Israel

Tehila Ben Moshe

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tehila Ben Moshe: Innovator in Antibody Development

Introduction

Tehila Ben Moshe is a prominent inventor based in Misgav, Israel. She has made significant contributions to the field of biotherapeutics, particularly in the development of antibodies targeting carcinoembryonic antigen-related cell adhesion molecules. With a total of 2 patents, her work is paving the way for advancements in cancer diagnosis and therapy.

Latest Patents

Tehila's latest patents focus on antibodies that recognize specific epitopes of the protein CEACAM1. These inventions provide antibodies and molecules that include at least the antigen-binding portion of an antibody. The disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Additionally, methods for the production and use of these antibodies in therapy and diagnosis are also provided.

Career Highlights

Throughout her career, Tehila has worked with notable companies such as Ccam Biotherapeutics Ltd. and Famewave Ltd. Her expertise in antibody development has positioned her as a key player in the biotherapeutics industry.

Collaborations

Tehila has collaborated with esteemed colleagues, including Gal Markel and Yair Sapir. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Tehila Ben Moshe is a trailblazer in the development of innovative antibodies, contributing to significant advancements in medical science. Her work continues to impact the landscape of cancer therapy and diagnosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…